Search - tctmd.com

Displaying 541 - 560 of 609

Sort: Relevancy | Date

Presentation TCT 2014

Position Statement: Heparin Will Once Again Become the Anticoagulant of Choice for PCI in Stable and Unstable Coronary Syndromes

Presenter: Kishore J. Harjai, Michael S. Lee

September 14, 2014

Presentation TCT 2014

Position Statement: Radial Intervention Will Become the First Choice for All Coronary Interventions, Including STEMI and Cardiogenic Shock

Presenter: Kishore J. Harjai, Samir B. Pancholy

September 14, 2014

Presentation TCT 2014

Cath Lab Director Perspective: Ensuring High Standards of Appropriate Care

Presenter: Julie Logan, Marian C. Hawkey, Manesh R. Patel

September 14, 2014

Presentation TCT 2014

STEMI Pharmacology: Ambulance, ER, Cath Lab, and CCU

Presenter: Luigi Salemme, Mohamed Sobhy

September 13, 2014

Presentation TCT 2014

Bailing Out the Interventionalist: When Is a Surgeon Really Needed?

Presenter: Liliana R. Grinfeld, Robert W. Yeh, Vinod H. Thourani

September 13, 2014

Presentation TCT 2014

Complications During Catheterization of Adults with Congenital Heart Disease

Presenter: Liliana R. Grinfeld, Robert W. Yeh, Chun Huie Lin

September 13, 2014

Presentation TCT 2014

Challenges for the Cath Lab Leader: From Credentialing to Conflict Resolution

Presenter: Peter L. Duffy, Sunil V. Rao, Ehtisham Mahmud

September 13, 2014

Presentation TCT 2014

Transradial Catheterization Complications

Presenter: Liliana R. Grinfeld, Robert W. Yeh, Mladen I. Vidovich

September 13, 2014

Presentation TCT 2014

The 2014 Cath Lab: Budget, Inventory, and New Technology

Presenter: Peter L. Duffy, Sunil V. Rao, Robert J. Applegate

September 13, 2014

Presentation TCT 2014

Valvular Migration During TAVR

Presenter: Liliana R. Grinfeld, Robert W. Yeh, Ganesh Manoharan

September 13, 2014

Presentation TCT 2014

Preloading P2Y12 Antagonists in NSTE-ACS and STEMI: Safe and Effective? What Regimens?

Presenter: Dominick J. Angiolillo

September 13, 2014

Presentation TCT 2014

Preventing, Recognizing, and Managing Aorto-Iliac Rupture in Big Catheter Procedures

Presenter: Liliana R. Grinfeld, Robert W. Yeh, Bernhard Reimers

September 13, 2014

Presentation TCT 2014

The Role of the Cath Lab Leader: Quality and Education

Presenter: Peter L. Duffy, Sunil V. Rao, Kirk N. Garratt

September 13, 2014

Presentation TCT 2014

Are GP IIb/IIIa Inhibitors Still Useful?

Presenter: Marco Valgimigli

September 13, 2014

Presentation TCT 2014

What is the SCAI Cath Lab Leadership Boot Camp?

Presenter: Peter L. Duffy, Sunil V. Rao, Charles E. Chambers

September 13, 2014

Presentation TCT 2014

Opening CTOs Cant Make Things Worse or Can It? The Spectrum of CTO- and PCI-Related Complications

Presenter: Liliana R. Grinfeld, Robert W. Yeh, Sudhir Rathore

September 13, 2014

Presentation TCT 2014

Antithrombin Alternatives: Pros and Cons

Presenter: Harold L. Dauerman

September 13, 2014

News Conference News TCT 2014

Bleeding, Arrhythmias Dominate Periprocedural Complication Costs for TAVR

September 13, 2014

News Conference News TCT 2014

TAVR Effective in High-Risk Patients at ‘Acceptable’ Cost

Todd Neale

September 13, 2014

Presentation TCT 2014

Cath Lab Room Setup

Presenter: Manish A. Parikh, Robert T. Pyo, Jonathan Feig

September 12, 2014

Advertisement

Position Statement: Heparin Will Once Again Become the Anticoagulant of Choice for PCI in Stable and Unstable Coronary Syndromes

Position Statement: Radial Intervention Will Become the First Choice for All Coronary Interventions, Including STEMI and Cardiogenic Shock

Cath Lab Director Perspective: Ensuring High Standards of Appropriate Care

STEMI Pharmacology: Ambulance, ER, Cath Lab, and CCU

Bailing Out the Interventionalist: When Is a Surgeon Really Needed?

Complications During Catheterization of Adults with Congenital Heart Disease

Challenges for the Cath Lab Leader: From Credentialing to Conflict Resolution

Transradial Catheterization Complications

The 2014 Cath Lab: Budget, Inventory, and New Technology

Valvular Migration During TAVR

Preloading P2Y12 Antagonists in NSTE-ACS and STEMI: Safe and Effective? What Regimens?

Preventing, Recognizing, and Managing Aorto-Iliac Rupture in Big Catheter Procedures

The Role of the Cath Lab Leader: Quality and Education

Are GP IIb/IIIa Inhibitors Still Useful?

What is the SCAI Cath Lab Leadership Boot Camp?

Opening CTOs Cant Make Things Worse or Can It? The Spectrum of CTO- and PCI-Related Complications

Antithrombin Alternatives: Pros and Cons

Bleeding, Arrhythmias Dominate Periprocedural Complication Costs for TAVR

TAVR Effective in High-Risk Patients at ‘Acceptable’ Cost

Cath Lab Room Setup

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content